GlassScriptPhysician profile
Tami R Ross
NPI 1285638627
$2,332.56
in general payments reported to CMS, 2019-2025
15 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $86.33 · 2021: $537 · 2022: $220 · 2023: $493 · 2024: $258 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $876 · Entertainment: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.06 |
| Entertainment | $261.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $657.97 | 2019-2025 | Tryptyr, Total30, Simbrinza |
| Johnson & Johnson Vision Care, INC. | $623.06 | 2019-2025 | Acuvue |
| Optos, INC. | $261.63 | 2023-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| The Cameron-Ehlen Group, INC. | $162.50 | 2021 | |
| Rxsight INC | $141.70 | 2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Ivantis, INC | $136.52 | 2019 | |
| Glaukos Corporation | $125.38 | 2021 | |
| Bausch & Lomb Americas INC. | $57.85 | 2022-2023 | |
| Abb Con-Cise Optical Group LLC | $50.05 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $27.82 | 2021 | |
| Astellas Pharma US INC | $23.08 | 2024 | Izervay |
| Genentech USA, INC. | $20.03 | 2025 | Venclexta |
| Harrow Eye, LLC | $18.11 | 2025 | Vevye |
| Coopervision INC. | $14.36 | 2023 | Myday Contact Lens |
| Shire North American Group INC | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tami Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.